FDA Drug Application (202124) for PARICALCITOL by RISING PHARMS INC

Back to FDA Applications sponsored by RISING PHARMS INC

Application Number202124
Product Number001
FormCAPSULE;ORAL
Dosage1MCG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePARICALCITOL
Active IngredientPARICALCITOL



Back to FDA Applications sponsored by RISING PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.